Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells (Q38955075)

7 September 2017

Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells (English)

1 reference

7 September 2017

0 references

Lan Yi

1

1 reference

7 September 2017

Yvonne Sun

series ordinal

2

1 reference

7 September 2017

Arnold Levine

series ordinal

3

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 October 2014

1 reference

7 September 2017

1 reference

7 September 2017

5

1 reference

7 September 2017

19

1 reference

7 September 2017

8924-8936

1 reference

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers.

7 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Regulation of p53 is critical for vertebrate limb regeneration

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Molecular classification of prostate cancer using curated expression signatures

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

A planarian p53 homolog regulates proliferation and self-renewal in adult stem cell lineages

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Suppression of induced pluripotent stem cell generation by the p53-p21 pathway

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

The Ink4/Arf locus is a barrier for iPS cell reprogramming

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

The history of cancer epigenetics

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

High metastatic potential in mice inheriting a targeted p53 missense mutation

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Senescence impairs successful reprogramming to pluripotent stem cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

The absence of p53 is critical for the induction of apoptosis by 5-aza-2'-deoxycytidine

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4253407

A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25238040

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

T-cell therapy at the threshold

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25238040

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.2441

0 references

1 reference

7 September 2017

PubMed publication ID

25238040

1 reference